Meet ApplyKite Twin, the application assistant that learns with you

Meet your Twin, it learns with you

Your Twin learns with you

Launch week codes:30% off annual Pro20% off monthly Pro

Ends in00h00m00s

Roberto Iacovelli

Has grant

Policlinico Universitario Agostino Gemelli

Italy

Research Interests

Explore related searches

Professors in Italy

Recent Grants

Grant: Close

RENAL-8: Studio Retrospettivo volto a valutare la correlazione ed il significato prognostico dell’EspressioNe del recettore per il fAttore di crescita dei fibrobLasti (FGFR) e l’interleukina 8 (IL-8) nel carcinoma renale metastatico

Open Date: 2013-11-01

Close Date: 2014-12-01

Articles (18)

Year:

2026

Year:

2026

Year:

2026

Year:

2026

Year:

2026

Year:

2026

Year:

2025

Year:

2025

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2023

Year:

2023

Year:

2023

Year:

2022

Collaborators (9)

Luigi Napolitano

Università degli Studi di Napoli Federico II

ITALY

View details

Filippo Gavi

Urologist

Agostino Gemelli University Polyclinic

ITALY

View details

Angelo Minucci

University of Padova

ITALY

View details

Filippo Marino

Policlinico Universitario Agostino Gemelli

ITALY

View details

Luigi Boccuto

UNITED STATES

View details

Paolo Zucali

Head of genitourinary cancers and rare tumors of the chest

Humanitas University

ITALY

View details

nazario foschi

Università Cattolica del Sacro Cuore

ITALY

View details

Emilio Sacco

Università Cattolica del Sacro Cuore

ITALY

View details

Chiara Leoni

MD, PhD

Agostino Gemelli University Polyclinic

ITALY

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Roberto Iacovelli

Research Interests

Explore related searches

Recent Grants

Articles (18)

A Narrative Review of da Vinci Single-Port Versus Multi-Port Robotic Surgery in Elderly or Frail Urological Cancer Patients

Correction: Schubert et al. Minimally Invasive Ablation Strategies for Renal Cell Carcinoma Patients Ineligible for Surgery. <i>Life</i> 2026, <i>16</i>, 73

Liquid Biopsy in Non-Metastatic Prostate Cancer: Clinical Evidence and Future Directions

Minimally Invasive Ablation Strategies for Renal Cell Carcinoma Patients Ineligible for Surgery

The ITALIC-RCC: A Randomized Trial on Clinical and Humoral Impact of Primary Tumor Ablation by Surgery or Radiotherapy in Metastatic Renal Cell Carcinoma Treated with Checkpoint Inhibitors

The Clinical Role of Hypoxia Inducible Factor (HIF) Inhibition in Renal Cancer: A Focus on Belzutifan

Prognostic Value of PLR, SIRI, PIV, SII, and NLR in Non-Muscle Invasive Bladder Cancer: Can Inflammatory Factors Influence Pathogenesis and Outcomes?

[Cost Evaluation of First-Year Treatment for Locally Advanced or Metastatic Urothelial Carcinoma with Chemotherapy Plus Avelumab vs Chemotherapy Plus Best Supportive Care: A Cost of Care Model]

Comparison of PIV and Other Immune Inflammation Markers of Oncological and Survival Outcomes in Patients Undergoing Radical Cystectomy

Avelumab Plus Intermittent Axitinib in Previously Untreated Patients with Metastatic Renal Cell Carcinoma. The Tide-A Phase 2 Study

Relationship Between Loss of Y Chromosome and Urologic Cancers: New Future Perspectives

Re: Thomas Powles, Zoe June Assaf, Viraj Degaonkar, et al. Updated Overall Survival by Circulating Tumor DNA Status from the Phase 3 IMvigor010 Trial: Adjuvant Atezolizumab Versus Observation in Muscle-invasive Urothelial Carcinoma. Eur Urol 2024;85:114–22

Clinical Outcomes and Prognostic Factors in Patients With Penile Carcinoma: A Sub-Analysis From Meet-URO 23 (I-RARE) Registry Study

The Role of the Complement in Clear Cell Renal Carcinoma (ccRCC)—What Future Prospects Are There for Its Use in Clinical Practice?

Navigating the Rapidly Evolving Advanced Urothelial Carcinoma Treatment Landscape: Insights from Italian Experts

Post nephrectomy management of localized renal cell carcinoma. From risk stratification to therapeutic evidence in an evolving clinical scenario

Management of metastatic urothelial carcinoma: Current approach, emerging agents, and future perspectives

Germline mutations in prostate cancer: a systematic review of the evidence for personalized medicine

Collaborators (9)

Luigi Napolitano

Filippo Gavi

Angelo Minucci

Filippo Marino

Luigi Boccuto

Paolo Zucali

nazario foschi

Emilio Sacco

Chiara Leoni

Make your next move.